Detalhe da pesquisa
1.
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.
Cell
; 174(6): 1586-1598.e12, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100188
2.
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
N Engl J Med
; 386(3): 241-251, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534430
3.
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.
Blood
; 142(18): 1570-1575, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595284
4.
Pan-cancer whole-genome analyses of metastatic solid tumours.
Nature
; 575(7781): 210-216, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31645765
5.
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial.
Lancet Oncol
; 25(4): 439-454, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547891
6.
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
Cancer
; 130(5): 683-691, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905752
7.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750115
8.
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer.
Tumour Biol
; 46(s1): S327-S340, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37270827
9.
Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients.
Ther Drug Monit
; 46(1): 73-79, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37348074
10.
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Future Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357801
11.
Long-term expanding human airway organoids for disease modeling.
EMBO J
; 38(4)2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643021
12.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
13.
Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
N Engl J Med
; 383(10): 931-943, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469185
14.
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer.
BMC Cancer
; 23(1): 247, 2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918817
15.
Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC.
N Engl J Med
; 390(4): 381, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265653
16.
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting.
Pharm Res
; 39(10): 2507-2514, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35978149
17.
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
Future Oncol
; 18(7): 781-791, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918546
18.
Detection of Circulating Tumor Cells Using the Attune NxT.
Int J Mol Sci
; 24(1)2022 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36613466
19.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Lancet Oncol
; 22(12): 1681-1691, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767759
20.
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
Oncologist
; 26(2): e306-e315, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33145902